EN DE

Business Alignment Public Company (BIZ) Fair Value & Analysis

Healthcare · TH · Market cap 3.7B THB

BA Business Alignment Public Company BIZ · BK
Price5.95 THB
Fair Value9.21 THB
Upside+54.8%
Quality62/100
Watch Business Alignment Public Company for free, get notified when fair value or trend changes. Watch for free
Expensive Growth
Solidly profitable · 16.8% net margin
Low debt · negative free cash flow
8.13% dividend yield
Ranks above peers (11/13)
Wide moat 77/100
Evidence: Medium Range 5.46 THB – 16.90 THB Share as image

Fair value as of: Jul 16, 2026

From 17 valuation models · updated 25 days ago

Share price −0.8% over the past month.

A solid business, screening 55% undervalued on our models.

What matters now

  • The model range is unusually wide (5.46 THB to 16.90 THB). The outcome hinges heavily on assumptions, so read the point estimate with caution.
  • Solid quality (62/100) at a price below fair value, the discount is the argument here, not the business quality.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

6.35 THB 1.61 THB Fair Value 9.21 THB Feb 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 16, 2026.

How to read this chart

60‑month range 1.61 THB – 6.35 THB · fair‑value band 5.46 THB – 16.90 THB · the 5.95 THB price screens below the 9.21 THB fair value. Dashed = 300-day average. As of Jul 16, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Business Alignment Public Company (BIZ) currently trades at 5.95 THB, while our model-based Fair Value estimate is 9.21 THB, implying the stock looks roughly 54.8% undervalued today. The Quality Score stands at 62/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.

Over the trailing twelve months, Business Alignment Public Company generated revenue of 2.4B THB at a net margin of 16.8%. Revenue grew 181.5% year over year. It earns a return on equity of 37.9%. Net debt stands at 214M THB. Fundamentals as of Jul 16, 2026

Our scenario range runs from 5.46 THB (bear case) to 16.90 THB (bull case); at 5.95 THB, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 8% below its 52-week high and 106% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -22% fair-value upside, at 55%, BIZ screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Residual Income 3.02 THB 3.68 THB 14.08 THB 76
ROIC Compounder 5.73 THB 7.73 THB 10.30 THB 72
Gordon GGM 3.07 THB 6.12 THB 9.27 THB 70
All 17 models by family
DCF Models
Owner Earnings 7.64 THB 15.70 THB 31.10 THB 31
Earnings-Based
Graham-Dodd 3.46 THB 21.66 THB 30.26 THB 54
Lynch FV 6.24 THB 8.92 THB 11.59 THB 50
PEG = 1.0 6.24 THB 8.92 THB 11.59 THB 46
EPV 4.89 THB 5.64 THB 6.29 THB 59
Dividend Discount
Gordon GGM 3.07 THB 6.12 THB 9.27 THB 70
DDM Multi-Stage 3.07 THB 5.29 THB 6.47 THB 61
Multiples
P/E Multiple 8.39 THB 11.19 THB 13.99 THB 63
P/S Multiple 6.49 THB 8.65 THB 10.81 THB 58
P/B Multiple 5.47 THB 7.29 THB 9.11 THB 55
EV/EBIT 8.41 THB 11.17 THB 13.94 THB 53
EV/EBITDA 7.28 THB 9.67 THB 12.06 THB 54
EV/Revenue 6.03 THB 8.57 THB 11.11 THB 43
Asset-Based
NCAV (Graham) 0.8100 THB 1.09 THB 1.62 THB 50
Economic Profit
Residual Income 3.02 THB 3.68 THB 14.08 THB 76
ROIC Compounder 5.73 THB 7.73 THB 10.30 THB 72
Growth Earnings
Growth-Adj P/E 9.10 THB 13.00 THB 16.90 THB 68

Widest divergence: DCF Models (15.70 THB) versus Asset-Based (1.09 THB). Highest evidence: Residual Income (76).

Notify me when BIZ reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 2.4B THB
Revenue growth (YoY) +182%
Net margin 16.8%
Return on equity 37.9%
Free cash flow −249M THB FY2025
P/E ratio 9.3
More key figures
Operating margin 23.8%
EPS (TTM) 0.6600 THB
Dividend yield 7.9%
EPS growth (YoY) +750%
Net debt 214M THB FY2025

Figures from reported company fundamentals · as of Jul 16, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 62/100

Of which business quality 58 · Market factors (momentum, volatility) 92

Profitability 75
Margins and returns on capital today
Quality Growth 64
Are margins and returns improving?
Cashflow 0
Earnings quality: real cash, not paper profit
Fin. Strength 76
Balance sheet, leverage, solvency risk
Investment 65
Disciplined investing over empire-building
Low Volatility 89
Calm price path (market factor)
Momentum 95
Price trend over the last 3–12 months (market factor)
52W Momentum 92
Distance to the 52-week high (market factor)
Net Issuance 84
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Business Alignment Public Company Limited sells medical equipment in Thailand. It operates through two segments, Sales of medical equipment and Hospital operations.

Full company description

Business Alignment Public Company Limited sells medical equipment in Thailand. It operates through two segments, Sales of medical equipment and Hospital operations. The company is also involved in medical equipment installation and related activities, such as building construction for locating medical equipment; provision of repair and maintenance; and medical equipment efficiency increasing services. In addition, it engages in the operation of specialized cancer treatment hospitals, including medical services, hospital rooms, medicines, and medical supplies. The company serves medical university-affiliated hospitals, cancer hospitals under the department of medical services, other government hospitals, public healthcare agencies, and private hospitals. Business Alignment Public Company Limited was incorporated in 2000 and is based in Bangkok, Thailand.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Business Alignment Public Company reported revenue of 2.0B THB in FY2025 versus 2.9B THB in FY2021, a compound −8.8%/yr. Reported net income was 306M THB in FY2025, compounding −7.7%/yr from FY2021.

Growth Quality 62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2025)
2.0B THB
Latest YoY
+18.1%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+18.2%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+21.8%
Avg. growth/yr (13Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+6.7%
Revenue −8.8%/yr
FY21 2.9B THB
FY22 1.2B THB
FY23 1.7B THB
FY24 1.7B THB
FY25 2.0B THB
Net income −7.7%/yr
FY21 420M THB
FY22 133M THB
FY23 201M THB
FY24 224M THB
FY25 306M THB
Character of growth · EPS growth decomposed (2014-2025) +4.2 % p.a.
Revenue per share −2.8 pp

of which total revenue +12.3 pp · buybacks/dilution −15.1 pp

EBIT margin +6.4 pp
Tax rate −0.2 pp
Residual (interest, one-offs) +0.9 pp

Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).

Watch BIZ: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Business Alignment Public Company Fair Value". https://www.fairvalue-calculator.com/stock/BIZ

Peer Group

Medical Devices · 352 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 62 · Above median
Fair Value upside +55% · Top 25%
Return on equity (TTM) 38% · Top 25%
Return on assets 16% · Top 25%
Net margin (TTM) 17% · Top 25%
Operating margin (TTM) 24% · Top 25%
Revenue growth 182% · Top 25%
Dividend yield (TTM) 8.1% · Top 25%
Debt / equity 0.09× · Higher than median

Valuation Multiples vs Medical Devices median · lower = cheaper

P/E (TTM) 9.2× · Cheaper than 75% of peers
P/B 3.76× · Pricier than 75% of peers
P/S (TTM) 1.55× · Cheaper than median
EV/EBITDA 7.0× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 100 · sector 0
FUTURE 100 · sector 29
PAST 100 · sector 8
HEALTH 95 · sector 97
DIVIDEND 100 · sector 38

Insider activity: 35/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).

Stock Price Fair Value vs Fair Value
Abbott Laboratories, ABT $100.68 $74.79 -26%
Stryker Corporation SYK $316.44 $186.28 -41%
Medtronic plc MDT $83.56 $65.57 -22%
Boston Scientific Corporation BSX $43.04 $38.44 -11%
Edwards Lifesciences Corporation EW $85.73 $41.02 -52%
Siemens Healthineers AG SHL €34.59 €33.87 -2%
Shenzhen Mindray Bio-Medical Electronics Co 300760 ¥149.43 ¥147.63 -1%
Shanghai United Imaging Healthcare Co 688271 ¥109.00 ¥43.60 -60%
Demant A/S DEMANT kr 276.60 kr 161.17 -42%
Getinge AB GETIB kr 206.80 kr 192.14 -7%

Compare Business Alignment Public Company with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Business Alignment Public Company (BIZ) overvalued or undervalued?
As of Jul 16, 2026, our model estimates a fair value of 9.21 THB versus a price of 5.95 THB, about +55% (undervalued).
What is the fair value of BIZ?
Our model-based fair value for Business Alignment Public Company is 9.21 THB (as of Jul 16, 2026), built from audited fundamentals. The current price is 5.95 THB.
What is the quality score of BIZ?
Business Alignment Public Company has a Quality Score of 62/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Business Alignment Public Company (BIZ)?
Business Alignment Public Company reported trailing-twelve-month revenue of about 2.4B THB (latest available figure, as of Jul 16, 2026).
What is the net profit margin of BIZ?
The net profit margin of Business Alignment Public Company is about 16.8%, meaning it keeps roughly 16.8% of revenue as net income. Based on the latest reported figures.
Does Business Alignment Public Company pay a dividend?
Business Alignment Public Company currently shows a dividend yield of about 7.87% relative to its recent price (as of Jul 16, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Business Alignment Public Company and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.